Skip to Content

  • Search

View Additional Section Content

ECOG – E1105 - A Randomizd Phase III Double-Blind Placebo-Controlled Trial of First-line Chemotherapy and Trastuzumab with or without Bevacizumab for Patients with HER-2 /NEU Overexpressing Metastatic Breast Cancer

Clinical Trial Categories

  • Breast Cancer
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details